Skip to main content
. 2023 Jun 15;15:100230. doi: 10.1016/j.lansea.2023.100230

Table 2.

For the Indian and multinational trials in Phase 3, the number and percentage of sites in each zone.

Trials in each zone 163 Indian trials
28 multinational trials
Number of sites Percentage Number of sites Percentage
Western 362 34.5 110 31.5
Southern 254 24.2 132 37.8
Northern 195 18.6 52 14.9
Central 113 10.8 22 6.3
Eastern 107 10.2 31 8.9
North-Eastern 18 1.7 2 0.6
Total 1049 100 349 100